Ranibizumab combined with verteporfin photodynamic therapy in neovascular age-related macular degeneration: year 1 results of the FOCUS Study. (Q34653066)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Ranibizumab combined with verteporfin photodynamic therapy in neovascular age-related macular degeneration: year 1 results of the FOCUS Study. |
scientific article |
Statements
Ranibizumab combined with verteporfin photodynamic therapy in neovascular age-related macular degeneration: year 1 results of the FOCUS Study (English)
Jeffrey S Heier
David S Boyer
Philip J Ferrone
J Michael Jumper
Ronald C Gentile
Debbi Kotlovker
Carol Y Chung
Robert Y Kim
FOCUS Study Group
1 November 2006